Jens Ducree,
Principal Investigator,
Dublin City University
Dr. Jens Ducrée holds a Full Professorship of Microsystems at Dublin City University (DCU) and has been the founding director of Ireland’s first Fraunhofer Project Centre. The main part of his research is directed towards novel microfluidic systems for the integration, automation of bioanalytical protocols . Typical applications of these next-generation “Lab-on-a-Chip” platforms are sample-to-answer systems for biomedical point-of-care and global diagnostics, liquid handling automation for the life sciences, process analytical techniques and cell line development for biopharma as well as monitoring the environment, infrastructure, industrial processes and agrifood. Dr. Ducrée has a keen interest in industrialisation of larger-scale integrated (LSI) Lab-on-a-Chip systems which is boosted by platform strategies; these efforts encompass design-for-manufacture and scale-up, digital twin concepts for virtual manufacture, testing, characterisation and optimisation, failure mode and effects analysis (FMEA), and standardisation to expedite and de-risk research & technology development (RTD). Dr. Ducrée also explores avenues for globalising and democratising science and RTD leveraged by novel trends such as crowdsourcing, foundry models, citizen science and the cryptoeconomy based on blockchain.
Towards Large Scale Integrated, Multivariate “Lab-on-a-Disc” Sensors by a Virtual “Digital Twin” Approach
Wednesday, 30 June 2021 at 10:00
Add to Calendar ▼2021-06-30 10:00:002021-06-30 11:00:00Europe/LondonTowards Large Scale Integrated, Multivariate “Lab-on-a-Disc” Sensors by a Virtual “Digital Twin” ApproachPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2021 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Future decentralized bioanalytical testing, e.g., for applications in point-of-care and global diagnostics as well as ubiquitous monitoring of industries, infrastructures and the environment, will require full sample-to-answer automation and parallelization of bioassays on widely autonomous or user-friendly, robust and cost-efficient systems. Centrifugal microfluidic technologies have already demonstrated comprehensive, high-performance process integration of bioassay protocols for a wide range of scientific endeavours and commercial applications. Based on a digital twin approach, this presentation outlines a virtual “in silico” approach to optimize performance, integration density, reliability, configurability and manufacturability of these “Lab-on-a-Disc” (LoaD) devices, thus decisively minimizing cost, risk and time-to-market. These advancements provide an entry gate for developing mature commercial supply chains, foundry services, standardization, validation, and even enable rapidly emerging, participatory research models based on disruptive 21st technologies at the crossroads of Internet of Things (IoT), Artificial Intelligence (AI) and the distributed ledger technology Blockchain.
Add to Calendar ▼2021-06-28 00:00:002021-06-30 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2021Point-of-Care, Biosensors and Mobile Diagnostics Europe 2021 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2021-06-30 10:00:002021-06-30 11:00:00Europe/LondonTowards Large Scale Integrated, Multivariate “Lab-on-a-Disc” Sensors by a Virtual “Digital Twin” ApproachPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2021 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
